All meeting attendees, members of the media, companies, institutions, organizations, universities, investment advisors, and all other individuals are required to abide by the embargo policy governing the Pediatric Endocrine Society (PES) 2024 Annual Meeting. This embargo policy means that information from any abstract or presentation is confidential and may not be announced, publicized, or distributed before the scheduled presentation at the PES meeting. All submissions are to be considered preliminary until the time of presentation. The purpose of the embargo policy is to protect the scientific integrity of the abstract submissions presented at the PES Scientific Sessions.

For PES members and guests, this policy means that you should not discuss your presentation with, nor provide additional information to, journalists before the time of presentation unless they guarantee that they will not publish their stories until the embargo lifts. Our policy is to release information about our content in a way that provides fair and equal access to the media, allowing it to provide informed comment based on the complete and final version of the presentation that is to be presented.

All abstracts will be published in Hormone Research in Paediatrics. Any and all use of this content must be authorized by Karger (the publisher). In other words, the author does not retain permission to re-use the abstracts following the meeting. Permission to re-use abstracts must be requested from Karger. For posters and oral presentations, the authors retain the rights for re-use.